TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 10 | -1 | -2 | -2 | -4 | -8 | 6 | -2 |
| S | %wins | 70 | 70 | 50 | 50 | 60 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/15 17:07 | 6/1/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | SVP,Busi | S.d | -384 | 51.19 | 19 | -8 | -62 | 5 | D | 97 | 42 | 28 | 10 | 2 | 3 | 1 | -1 | 3 | 0 | 4 | 4 | -18 | -16 |
6/2/15 17:07 | 5/29/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | SVP,Busi | S.d | -1,154 | 51.17 | 19 | -23 | -83 | 5 | D | 97 | 42 | 28 | 10 | 2 | 3 | 1 | -1 | 3 | 0 | 4 | 4 | -18 | -16 |
3/19/15 16:35 | 3/17/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | SVP,Busi | S.d | -1,213 | 48.53 | 31 | -25 | -85 | 5 | D | 104 | 32 | 21 | 34 | 20 | 7 | 4 | -1 | 0 | -3 | 3 | 3 | 11 | 3 |
12/12/14 13:12 | 12/11/14 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | SVP,Busi | S.d | -1,853 | 37.07 | 17 | -50 | -92 | 5 | D | 94 | 10 | 6 | 1 | -8 | -8 | -6 | -2 | -2 | 3 | 13 | 32 | 35 | 5 |
8/9/12 16:50 | 8/7/12 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | SVP,Busi | S.d | -222 | 18.96 | 9 | -12 | -82 | 3 | D | -36 | -20 | -31 | -17 | 0 | -7 | -1 | 1 | 0 | 3 | 5 | -5 | 17 | 75 |
7/23/12 15:25 | 7/19/12 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | VP,Strat | S.d | -95 | 20.00 | 9 | -5 | -64 | 3 | D | -29 | -47 | -14 | -19 | -2 | -1 | 1 | 1 | -4 | -5 | -3 | 7 | 8 | 50 |
4/30/12 15:19 | 4/26/10 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | VP,Strat | S.d | -87 | 25.00 | 20 | -3 | -57 | 3 | D | -36 | -31 | 6 | 6 | -1 | 10 | 10 | 7 | -7 | -15 | -27 | -28 | -25 | 1 |
3/9/12 11:45 | 3/7/12 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | VP,Strat | S.d | -109 | 25.00 | 13 | -4 | -62 | 3 | D | -36 | -33 | 8 | 11 | 8 | -1 | 0 | 3 | 1 | 0 | -9 | -25 | -27 | -7 |
2/9/12 15:02 | 2/7/12 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | VP,Strat | S.d | -137 | 25.10 | 20 | -5 | -67 | 3 | D | -35 | -33 | 15 | 2 | 13 | 17 | 11 | 3 | -1 | -3 | -2 | -17 | -31 | -20 |
2/6/12 16:36 | 2/2/12 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | VP,Strat | S.d | -170 | 25.00 | 16 | -7 | -72 | 3 | D | -37 | -35 | -3 | -1 | 14 | 16 | 12 | 7 | -3 | 2 | -4 | -13 | -27 | -13 |
11/21/07 16:05 | 11/20/07 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bridgen John | MA | O | VP,Strat | S.d | -795 | 59.18 | 0 | -13 | -84 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |